Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer
Public ClinicalTrials.gov record NCT02872116. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Open-Label, Phase 3 Study of Nivolumab Plus Ipilimumab or Nivolumab in Combination With Oxaliplatin Plus Fluoropyrimidine Versus Oxaliplatin Plus Fluoropyrimidine in Subjects With Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
Study identification
- NCT ID
- NCT02872116
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 2,031 participants
Conditions and interventions
Interventions
- Capecitabine Drug
- Fluorouracil Drug
- Ipilimumab Drug
- Leucovorin Drug
- Nivolumab Drug
- Oxaliplatin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 11, 2016
- Primary completion
- May 26, 2020
- Completion
- Jun 5, 2024
- Last update posted
- Aug 6, 2025
2016 – 2024
United States locations
- U.S. sites
- 27
- U.S. states
- 15
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0005 | Los Angeles | California | 90033 | — |
| Local Institution - 0001 | San Francisco | California | 94115-1932 | — |
| Local Institution - 0066 | Aurora | Colorado | 80045 | — |
| Local Institution - 0151 | Denver | Colorado | 80218 | — |
| Local Institution - 0136 | Washington D.C. | District of Columbia | 20007 | — |
| Florida Cancer Specialists S. | Fort Myers | Florida | 33901 | — |
| Local Institution - 0147 | Miami | Florida | 33176 | — |
| Florida Cancer Specialists | St. Petersburg | Florida | 33705 | — |
| Local Institution - 0179 | Marietta | Georgia | 30060 | — |
| Local Institution - 0219 | Arlington Heights | Illinois | 60005 | — |
| Local Institution - 0120 | Chicago | Illinois | 60611 | — |
| Local Institution - 0021 | Baltimore | Maryland | 21224 | — |
| Local Institution - 0002 | Boston | Massachusetts | 02215 | — |
| Local Institution - 0135 | Boston | Massachusetts | 02215 | — |
| Local Institution - 0003 | New York | New York | 10065 | — |
| Local Institution - 0138 | Cleveland | Ohio | 44106 | — |
| Local Institution - 0186 | Cleveland | Ohio | 44195 | — |
| Local Institution - 0146 | Eugene | Oregon | 97401 | — |
| Lehigh Valley Health Network | Allentown | Pennsylvania | 18105 | — |
| Local Institution - 0065 | Pittsburgh | Pennsylvania | 15212 | — |
| Local Institution - 0104 | Nashville | Tennessee | 37203 | — |
| Local Institution - 0140 | Bedford | Texas | 76022 | — |
| Local Institution - 0143 | Dallas | Texas | 75230 | — |
| Local Institution - 0213 | Dallas | Texas | 75246 | — |
| Local Institution - 0004 | Houston | Texas | 77030 | — |
| Texas Oncology-Plano East | Plano | Texas | 75075-7787 | — |
| Local Institution - 0150 | Newport News | Virginia | 23606 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 152 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02872116, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 6, 2025 · Synced May 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02872116 live on ClinicalTrials.gov.